Marinus Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
MRNS Marinus Pharmaceuticals Inc
CIO City Office REIT Inc
HMHC Houghton Mifflin Harcourt Co
PBA Pembina Pipeline Corp
ZTS Zoetis Inc
HMPT Home Point Capital Inc
KWR Quaker Chemical Corp
TWO Two Harbors Investment Corp
BV Brightview Holdings Inc
PBPB Potbelly Corp
Go

Health Care : Pharmaceuticals | Small Cap Blend
Company profile

Marinus Pharmaceuticals Inc is a United States-based biopharmaceutical company. The Company offers development and commercialization of medical drugs for the treatment of serious neurological and psychiatric disorders such as epilepsy, post-traumatic stress, and fragile-x syndrome. Its clinical-stage product candidate, ganaxolone, is a modulator being developed in various dose forms, including intravenous, oral capsule and oral liquid, intended to provide more treatment options to adult and pediatric patient populations in both acute and chronic care settings.

Closing Price
$13.73
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
177,328
0
  • Prev Close
    13.73
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    177.3K
  • Last (time)
    3:59p ET 05/06/21
  • Last (size)
    1.3K
  • 52-Wk Range
    6.04 - 20.04
    LowHigh
  • (07/29/20 - 03/10/21)
    31.49%
  • 84.4%
  • Market Cap
    503.0M
  • Shares Outstanding
    36.6M
  • -3.05
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.4
  • 86.97
  • (% of float 04/15/21)
    12.49

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.